AtaiBeckley (ATAI) Tax Provisions (2020 - 2026)
AtaiBeckley (ATAI) recorded quarterly Tax Provisions of $200000.0 in Q1 2026, up 28.21% quarter-over-quarter from $156000.0 in Q1 2025, and up 28.21% on a YoY basis from $156000.0 in Q1 2025.
AtaiBeckley (ATAI) Tax Provisions (2020 - 2026) Analysis & Trends
AtaiBeckley has disclosed Tax Provisions across 6 years of filings, most recently posting $131000.0 for Q3 2025.
- Tax Provisions for Q3 2025 came in at $131000.0, up 173.6% year-over-year; the trailing twelve-month figure through Sep 2025 was $543000.0 (up 132.21% YoY), and the FY2024 annual result was $356000.0, up 135.04% from the prior year.
- Tax Provisions was $200000.0 for Q1 2026 at AtaiBeckley, up from $156000.0 in the prior quarter.
- In the past five years, Tax Provisions ranged from a high of $200000.0 in Q1 2026 to a low of $156000.0 in Q1 2025.
- The 5-year median for Tax Provisions is $131000.0 (2025), against an average of $512894.7.
- Across the five-year window, Tax Provisions soared 9900.0% in 2021 and plunged 174.79% in 2024, its largest moves.
- AtaiBeckley's Tax Provisions stood at $3.6 million in 2021, then jumped by 68.74% to $6.0 million in 2022, then sank by 126.72% to -$1.6 million in 2023, then soared by 109.73% to $156000.0 in 2024, then dropped by 16.03% to $131000.0 in 2025.
- The last three Tax Provisions figures came in at $131000.0 (Q3 2025), $100000.0 (Q2 2025), and $156000.0 (Q1 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | -11.20 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | 216,000.00 |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | -859,000.00 |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 221.50 Mn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | AtaiBeckley | 1.45 Bn | 1.45 Bn | - | 200,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 200,000.00 |
| Sep 30, 2025 | 131,000.00 |
| Jun 30, 2025 | 100,000.00 |
| Mar 31, 2025 | 156,000.00 |
| Mar 31, 2025 | 156,000.00 |
| Dec 31, 2024 | 156,000.00 |
| Sep 30, 2024 | -178,000.00 |
| Jun 30, 2024 | 100,000.00 |
| Mar 31, 2024 | -4,000.00 |
| Dec 31, 2023 | -1.60 Mn |
| Sep 30, 2023 | 238,000.00 |
| Jun 30, 2023 | 200,000.00 |
| Mar 31, 2023 | 200,000.00 |
| Dec 31, 2022 | 6.00 Mn |
| Sep 30, 2022 | 135,000.00 |
| Jun 30, 2022 | 51,000.00 |
| Mar 31, 2022 | 41,000.00 |
| Dec 31, 2021 | 3.56 Mn |
| Sep 30, 2021 | 400,000.00 |
| Jun 30, 2021 | 58,000.00 |